[1]ZHU C, QI X, LI H, et al.Correlation of serum liver fibrosis markers with severity of liver dysfunction in liver cirrhosis:a retrospective cross-sectional study[J].Int J Clin Exp Med, 2015, 8 (4) :5989-5998.
|
[2]WEI S, NIU M, WANG J, et al.A network pharmacology approach to discover active compounds and action mechanisms of San-Cao Granule for treatment of liver fibrosis[J].Drug Des Devel Ther, 2016, 10:733-743.
|
[3]Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association, Chinese Medical Association.Guidelines for prevention and treatment of alcoholic liver disease (revised version 2010) [J].J Clin Hepatol, 2010, 26 (3) :229-232. (in Chinese) 中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南 (2010年修订版) [J].临床肝胆病杂志, 2010, 26 (3) :229-232.
|
[4]CHEN GF, LI B, CHEN SH.Research in the progress of non-invasive diagnosis of liver fibrosis[J].Med Res, 2011, 40 (4) :15-18. (in Chinese) 陈国凤, 李冰, 陈松海.肝纤维化无创性诊断的研究进展[J].医学研究杂志, 2011, 40 (4) :15-18.
|
[5]Expert Committee on Clinical Application of Instantaneous Elastic Imaging Technology (TE) .Instantaneous elastic imaging technology (te) expert advisor on clinical applications (2015) [J/CD].Chin J Liver Dis:Electronic Edition, 2015, 7 (2) :12-18. (in Chinese) 瞬时弹性成像技术 (TE) 临床应用共识专家委员会.瞬时弹性成像技术 (TE) 临床应用专家共识 (2015年) [J/CD].中国肝脏病杂志:电子版, 2015, 7 (2) :12-18.
|
[6] CE SRZB.Mongolian internal medicine[M].Hohhot:Inner Mongolia People's Publishing House, 2011:187, 196. (in Chinese) 策·苏荣扎布.蒙医内科学[M].呼和浩特:内蒙古人民出版社, 2011:187, 196.
|
[7] MA HYN, BI LZN.Medication on the Mongolian version (M) .Chifeng:Inner Mongolia Science and Technology Press, 1985:165-166. (in Chinese) 马哈也那, 比卢遮那.医药月帝 (蒙文版) (M) .赤峰:内蒙古科学技术出版社, 1985:165-166.
|
[8]YUTUO YDGB.Four medical code[M].Shanghai:Shanghai Science and Technology Press, 1987:145-146, 169-170. (in Chinese) 宇妥·元丹贡布.四部医典[M].上海:上海科学技术出版社, 1987:145-146, 169-170.
|
[9]BAI QY, CE SRZB, SU HBLG.Chinese Medical Encyclopedia (Mongolian Medicine) [M].Shanghai:Shanghai science and Technology Press, 1992:125, 269. (in Chinese) 白清云, 策·苏荣扎布, 苏和毕力格.中国医学百科全书 (蒙医学) [M].上海:上海科学技术出版社, 1992:125, 269.
|
[10]HASI QQG, SE TY.Treatment of alcoholic liver fibrosis with Mongolian medicine[J].J Med Pharm Chin Minorities, 2013, 6 (35) :21-22. (in Chinese) 哈斯其其格, 色图雅.酒精性肝纤维化的蒙医治疗[J].中国民族医药杂志, 2013, 6 (35) :21-22.
|
[11]ZHONG ZZ, YU QL.Self-made Xingpi yanggan decoction in treatment of liver function and related parameters of liver fibrosis due to alcoholic liver disease[J].Chin Arch Tradit Chin Med, 2017, 3:752-754. (in Chinese) 钟之洲, 郁清琳.醒脾养肝汤治疗酒精性肝病对肝功能、肝纤维化相关指标的影响[J].中华中医药学刊, 2017, 3:752-754.
|
[12]GE HY, ZHAO BS, ZHANG SH, et al.Clinical effect of Mongolian drug Qinggan Jiuwei powder in treatment of alcoholic hepatitis[J].J Clin Hepatol, 2016, 32 (10) :1947-1950. (in Chinese) 戈宏焱, 赵百岁, 张仕华, 等.蒙药清肝九味散治疗酒精性肝炎的效果观察[J].临床肝胆病杂志, 2016, 32 (10) :1947-1950.
|
[13]YIN P, CUI HR, ZHANG CE, et al.Protective effects of Liuwei Wuling tablet on acute alcoholic-induced liver injury in mice[J].China J Chin Mater Med, 2016, 41 (19) :3637-3642. (in Chinese) 尹萍, 崔鹤蓉, 章从恩, 等.六味五灵片对小鼠急性乙醇性肝损伤的保护作用及机制初步研究[J].中国中药杂志, 2016, 41 (19) :3637-3642.
|
[14]WANG XL, LU BJ.Ruan Gan granule in mice caused by carbon tetrachloride liver fibrosis model[J].J Changchun Univ Chin Med, 2015, 31 (5) :911-913. (in Chinese) 王学良, 卢秉久.软肝冲剂对四氯化碳所致小鼠肝纤维化模型的影响[J].长春中医药大学学报, 2015, 31 (5) :911-913.
|
[15]WANG XQ, TIAN QQ, LI YH, et al.Immunoregulatory effect of Buyang Huanwu decoction on experimental autoimmune encephalomyelitis mice[J].Chin J Immunol, 2017, 33 (1) :52. (in Chinese) 王晓庆, 田倩倩, 李艳花, 等.补阳还五汤对EAE小鼠免疫调节的作用[J].中国免疫学杂志, 2017, 33 (1) :52.
|
[16]WANG ZW, SHAO J, GUO M, et al.Effect of total flavonoids and alkaloids from Meconopsis quintuplinervia on hepatic fibrosis in rat[J].Chin Tradit Patent Med, 2013, 35 (6) :1125-1128. (in Chinese) 王志旺, 邵晶, 郭玫, 等.五脉绿绒蒿总黄酮和总生物碱抗大鼠肝纤维化[J].中成药, 2013, 35 (6) :1125-1128.
|